Public hospital referrals

Waikato, Bay of Plenty and Lakes DHB’s have appointed Midland PET-CT as their preferred supplier of adult oncology PET-CT scanning services. PET-CT referrals for DHB funded scans are co-ordinated through PET-CT co-ordinators based in the respective base hospitals of the DHB’s:

Waikato DHB

Robyn Cavanah
Tel: 07 839 8899 ext 23049 or 89503
Mob: 021 549 727
Fax: 07 858 0978
Internal Fax: 94978
Email: Robyn.Cavanah@waikatodhb.health.nz

Valerie Meredith
Tel: 07 839 8899  
Email: Valerie.Meredith@WaikatoDHb.health.nz

Bay of Plenty DHB

Lorraine Hammersley
Tel: 07 579 8053
Locator:
Fax: 07 571 4924
Email: Lorraine.Hammersley@bopdhb.govt.nz

Lakes DHB

Una Bustany
Tel: 07 349 7901
Fax: 07 349 7952
Email: Una.Bustany@lakesdhb.govt.nz

Referral Criteria

As part of the “Cancer Control Strategy”, the Ministry has provided DHB’s with some funding for a limited number of indications, to facilitate improved national access to PET scanning and has identified the importance of PET-CT as a tool which aids clinical decision making for some patients with Cancer. Further information regarding criteria can be obtained at: http://www.moh.govt.nz . The criteria may be subject to change in the future.

Cancer        Clinical Indication

Colorectal     
    Preoperative evaluation for patients considered for resection of hepatic/lung metastases in colorectal carcinoma (CRC).
    Evaluation of residual structural abnormality on diagnostic imaging following definitive treatments for colorectal carcinoma (CRC)
.

Lung     
    Staging of proven non-small-cell lung cancer (NSLC) prior to curative or radiotherapy.
    Solitary pulmonary nodules not amenable to fine needle aspiration (FNA) or which have failed pathological characterisation
.

Lymphoma     
    Restaging of residual mass for Non Hodgkin’s Lymphoma following definitive treatment.
    Staging of early stage low grade non Hodgkin’s lymphoma.
    Staging of Hodgkin’s Disease


Head and neck     
    Restaging of residual neck masses in head and neck cancers following radiotherapy/chemotherapy.
    Staging for metastatic squamous carcinoma in cervical lymph nodes from unknown primary
.

Oesophagus     
    Staging of gastric/oesophageal cancer for curative treatment.

Malignant Melanoma     
    Patients considered for definitive or adjuvant treatment of oligo-metastatic or regional melanoma.

 Cervical             
     Staging of locally advanced cervical cancer for curative radiation treatment.

 Ovarian         
     Restaging of recurrent ovarian carcinoma being considered for cytoreductive surgery.

All adult oncology PET-CT scan requests will be based on the national clinical indications. Requests for DHB funded PET scans will only be considered from senior medical officers. Cases outside these criteria will be assessed by the Midland Regional Variance Committee.

Requests must be for patients who are eligible to receive publicly funded health and disability services, and being assessed by a hospital specialist to receive publicly funded hospital treatment. Hospital event history may be checked as part of the PET scan request authorising and auditing processes.

Exclusions:
Patients receiving services from any private specialist.
Patients receiving services (e.g. assessment, investigations and surgery) through a private service provider.
PET scans request which do not meet nationally agreed clinical indications and which are not approved by the Midland Regional Variance Committee.



Contact Us

Contact Us

Midland PET-CT is located in central Hamilton:

View Location MapGate 3,
Anglesea Clinic Complex,
54 Tristram St,
Hamilton

Our contact details are:

Freephone: 0800 4 A PETCT (0800 4 273 828)
 P. (07) 834 1470
 F. (07) 839 5780
 E. info@midlandpetct.co.nz

Please use the contact form for any non-urgent enquiries.
Feedback

Feedback

We continually strive to improve our services and we value your feedback.

Copyright 2017 Midland PET-CT